Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02469675 · ClinicalTrials.gov registry record · NA

Brain and Nerve Stimulation for Hand Muscles in Spinal Cord Injury and ALS

A NA study of Amyotrophic Lateral Sclerosis (ALS) and Spinal Cord Injury (SCI), sponsored by Bronx VA Medical Center.

Completed
Registry status
NA
Development phase
39
Enrollment target
1
Study location

NCT02469675 is a NA study of Amyotrophic Lateral Sclerosis (ALS) and Spinal Cord Injury (SCI) that has completed, run by Bronx VA Medical Center. The registered enrollment target is 39 participants, below the 259-participant average among 17 other Amyotrophic Lateral Sclerosis (ALS) trials with a reported enrollment target (85% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02469675, a NA study of Amyotrophic Lateral Sclerosis (ALS) and Spinal Cord Injury (SCI), has completed, sponsored by Bronx VA Medical Center.

COMPLETED
Registry status
NA
Development phase
39 participants
Enrollment target
1
Study location

Study Summary

Most neurological injuries such as spinal cord injuries (SCI) and amyotrophic lateral sclerosis (ALS) spare a portion of nerve circuitry. Strengthening spared nerve circuits may be an important method to improve functional recovery. In this study, the investigators aim to use non-invasive magnetic and electrical stimulation to strengthen motor circuits between the brain and hands. Magnetic stimulation will be used over the motor cortex (scalp). Two methods of electrical stimulation will be compared: stimulation of the median nerve at the wrist; or direct stimulation of the cervical spinal cord across the skin on the back of the neck. Several different combinations of magnetic and electrical stimulation will be compared to find the conditions that best strengthen nerve circuits between the brain and hands - "Fire Together, Wire Together". PLEASE NOTE, THIS IS A PRELIMINARY STUDY. This study is testing for temporary changes in nerve transmission and hand function. THERE IS NO EXPECTATION OF LONG-TERM BENEFIT FROM THIS STUDY. If we see temporary changes in this study, then future studies would focus on how to prolong that effect.

Conditions Studied

Amyotrophic Lateral Sclerosis (ALS) Spinal Cord Injury (SCI)

Interventions

  • DEVICE Transcranial magnetic stimulation
  • DEVICE Median nerve stimulation
  • DEVICE Cervical transcutaneous stimulation

Study Locations (1)

New York

  • James J. Peters VA Medical Center, Bronx, NY - The Bronx

Trial Details

FieldValue
Enrollment Target 39 participants
Start Date 2015-06
Est. Completion 2018-07-31
Phase NA

Sponsor

Bronx VA Medical Center

13 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT02469675

The ClinicalTrials.gov registry entry for NCT02469675 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 39 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 259-participant average among 17 other Amyotrophic Lateral Sclerosis (ALS) trials with a reported enrollment target (85% lower). The listed sponsor is Bronx VA Medical Center, which has 13 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Amyotrophic Lateral Sclerosis (ALS) appearing as the primary indexed condition, and to 3 interventions - of which Transcranial magnetic stimulation is the first listed.

NCT02469675 reports 1 study location spanning 1 distinct geographic area - top geographies include New York.

Frequently Asked Questions

What is clinical trial NCT02469675 about?

NCT02469675 is a clinical study titled "Brain and Nerve Stimulation for Hand Muscles in Spinal Cord Injury and ALS". Most neurological injuries such as spinal cord injuries (SCI) and amyotrophic lateral sclerosis (ALS) spare a portion of nerve circuitry. Strengthening spared nerve circuits may be an important method to improve functional recovery. In this study, the investigators aim to use non-invasive magnetic ...

What is the current status of trial NCT02469675?

This trial is currently completed. It is a NA study. The enrollment target is 39 participants. The study started on 2015-06. Estimated completion is 2018-07-31.

What conditions does trial NCT02469675 study?

This clinical trial studies the following conditions: Amyotrophic Lateral Sclerosis (ALS), Spinal Cord Injury (SCI).

What interventions are being tested in trial NCT02469675?

The interventions under investigation include: Transcranial magnetic stimulation (DEVICE), Median nerve stimulation (DEVICE), Cervical transcutaneous stimulation (DEVICE).

Who is sponsoring clinical trial NCT02469675?

This trial is sponsored by Bronx VA Medical Center, which has 13 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT02469675 being conducted?

This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Amyotrophic Lateral Sclerosis (ALS)

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Amyotrophic Lateral Sclerosis (ALS)

All registered trials for this condition

Spinal Cord Injury (SCI)

All registered trials for this condition

New York

All trials with a study site in New York

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.